Knocking down of Xkr8 enhances chemotherapy efficacy through modulating tumor immune microenvironmentConner McCarthyAug 16, 20240 min readSong et al._2024 JCR_Knocking down of Xkr8 enhances chemotherapy efficacy through tumor imDownload _2024 JCR_KNOCKING DOWN OF XKR8 ENHANCES CHEMOTHERAPY EFFICACY THROUGH TUMOR IM • 7.80MB
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapyThe multifaceted chemo-immune resistance is the principal barrier to achieving cure in cancer patients. Identifying a target that is...
Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapySirnaMed Featured in this example news article
Comments